This inventor holds 1 USPTO granted patent. Top assignees: Nationwide Children's Hospital, The Ohio State University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023
Title: Arthur H M Burghes: Innovator in Gene Therapy
Introduction
Arthur H M Burghes is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of lower motor neuron diseases. His innovative work has the potential to improve the lives of many patients suffering from these conditions.
Latest Patents
Arthur H M Burghes holds a patent for the "Intrathecal delivery of recombinant adeno-associated virus 9." This invention relates to methods and materials useful for the intrathecal delivery of polynucleotides. The patent indicates that the use of these methods is beneficial for treating lower motor neuron diseases such as Spinal Muscular Atrophy (SMA) and Amyotrophic Lateral Sclerosis (ALS), as well as Pompe disease and lysosomal storage disorders. The invention discloses that the administration of a non-ionic, low-osmolar contrast agent, along with a rAAV9 vector for the expression of Survival Motor Neuron protein, enhances the survival of SMN mutant mice compared to the administration of the expression vector alone.
Career Highlights
Throughout his career, Arthur H M Burghes has worked with esteemed institutions such as Nationwide Children's Hospital and The Ohio State University. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Brian K Kaspar and Paul N Porensky. Their collaborative efforts have further advanced the research and development of gene therapy techniques.
Conclusion
Arthur H M Burghes is a pioneering inventor whose work in gene therapy holds promise for treating serious medical conditions. His contributions to the field are invaluable and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile